Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学IBD and Cancer Risk, Ulcerative Colitis

Stephen Hanauer

MD

🏢Northwestern University Feinberg School of Medicine🌐USA

Clifford Joseph Barborka Professor of Medicine

105
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Stephen Hanauer is a leading US IBD clinician-investigator who has shaped ulcerative colitis therapeutic guidelines and thiopurine use patterns. He contributed to key trials of infliximab and adalimumab in IBD and has been central to AGA IBD guideline development. His work influenced current thinking on thiopurine lymphoma risk and cancer surveillance.

Share:

🧪Research Fields 研究领域

ulcerative colitis therapy
azathioprine thiopurines
IBD guidelines
colitis cancer surveillance
top-down therapy

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Stephen Hanauer 的研究动态

Follow Stephen Hanauer's research updates

留下邮箱,当我们发布与 Stephen Hanauer(Northwestern University Feinberg School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment